3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide

C31H47N3O7 — CID 158200065

IUPAC3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide
SMILESCCC(CC)CCCc1cc(N(C)C)c2c(c1O)C(O)=C1C(=O)[C@](O)(C(=O)CC(N)=O)[C@H](C(CO)N(C)C)C[C@@H]1C2
InChIInChI=1S/C31H47N3O7/c1-7-17(8-2)10-9-11-18-14-22(33(3)4)20-12-19-13-21(23(16-35)34(5)6)31(41,24(36)15-25(32)37)30(40)26(19)29(39)27(20)28(18)38/h14,17,19,21,23,35,38-39,41H,7-13,15-16H2,1-6H3,(H2,32,37)/t19-,21-,23?,31+/m0/s1
InChIKeyZBSPOJUSBAXEQM-NHXLKVDVSA-N
MW573.73 g/mol
LogP2.35
Rot. Bonds13

About 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide

3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide (PubChem CID 158200065) has the molecular formula C31H47N3O7 and a molecular weight of 573.73 g/mol. Its IUPAC name is 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide.

Molecular Properties

Compound Name3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide
PubChem CID158200065
Molecular FormulaC31H47N3O7
Molecular Weight573.73 g/mol
Exact Mass573.34
IUPAC Name3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide
SMILESCCC(CC)CCCc1cc(N(C)C)c2c(c1O)C(O)=C1C(=O)[C@](O)(C(=O)CC(N)=O)[C@H](C(CO)N(C)C)C[C@@H]1C2
InChIInChI=1S/C31H47N3O7/c1-7-17(8-2)10-9-11-18-14-22(33(3)4)20-12-19-13-21(23(16-35)34(5)6)31(41,24(36)15-25(32)37)30(40)26(19)29(39)27(20)28(18)38/h14,17,19,21,23,35,38-39,41H,7-13,15-16H2,1-6H3,(H2,32,37)/t19-,21-,23?,31+/m0/s1
InChIKeyZBSPOJUSBAXEQM-NHXLKVDVSA-N
XLogP2.35
TPSA164.63 Ų
H-Bond Donors5
H-Bond Acceptors9
Rotatable Bonds13
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500573.73
LogP ≤ 52.35
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide?
The IUPAC name of 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide (CID 158200065) is 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide.
What is the SMILES notation for 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide?
The canonical SMILES for 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide is CCC(CC)CCCc1cc(N(C)C)c2c(c1O)C(O)=C1C(=O)[C@](O)(C(=O)CC(N)=O)[C@H](C(CO)N(C)C)C[C@@H]1C2.
What is the InChIKey of 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide?
The InChIKey is ZBSPOJUSBAXEQM-NHXLKVDVSA-N. The full InChI is InChI=1S/C31H47N3O7/c1-7-17(8-2)10-9-11-18-14-22(33(3)4)20-12-19-13-21(23(16-35)34(5)6)31(41,24(36)15-25(32)37)30(40)26(19)29(39)27(20)28(18)38/h14,17,19,21,23,35,38-39,41H,7-13,15-16H2,1-6H3,(H2,32,37)/t19-,21-,23?,31+/m0/s1.
What are the key properties of 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide?
3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide has a molecular weight of 573.73 g/mol, XLogP of 2.35, 13 rotatable bonds, 5 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(2R,3S,4aR)-5-(dimethylamino)-3-[1-(dimethylamino)-2-hydroxyethyl]-7-(4-ethylhexyl)-2,8,9-trihydroxy-1-oxo-3,4,4a,10-tetrahydroanthracen-2-yl]-3-oxopropanamide is sourced from PubChem (CID 158200065), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).